Purchase Order 75F40126P00285
Award Date 9/9/26
Potential Completion Date 12/9/31
Potential Value $275K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Glen Burnie, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Food and Drug Administration awarded a purchase order to Axion Biosystems, Inc. for a multielectrode array system valued at $285,745.00 on September 8, 2025. No set-aside applied. Place of performance is Silver Spring, Maryland. The order carries a firm fixed price and an ultimate completion date of September 4, 2030.</p>
- <p>The Food and Drug Administration issued a delivery order to Axion Biosystems, Inc. on August 18, 2026, with a ceiling value of $51,900 for Axion multi-well plates for use in the multielectrode array (MEA) Maestro system. The order is firm fixed price and completes on September 30, 2026. Place of performance is Atlanta, Georgia.</p>
- This is a $140,204.00 firm-fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services' Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the delivery of a Micro-Electrode Assay System, a specialized laboratory instrument used in biomedical research initiatives across agencies like the National Institutes of Health (NIH), EPA, and VA. As a small business set-aside, this award...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Maxwell Biosystems AG, a for-profit manufacturer, for a MaxTwo Multi-Electrode Array (MEA) system. The $176,600 contract provides a high-density, CMOS-based MEA platform with 26,400 electrodes to support the institute's research into induced pluripotent stem cell-derived neurons and neuropsychiatric disorders. The system...
- This is a $130,289 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The contract is for the delivery of Axion's proprietary Maestro multi-electrode array (MEA) systems, Maestro Apex automated incubators, and related accessories like optical stimulation modules...
- This federal contract award is for the procurement of microelectrode array (MEA) lab equipment, including the Maestro multi-well MEA system, from Axion Biosystems, Inc. The $163,750.00 firm fixed-price purchase order was issued by the Department of Health and Human Services' Food and Drug Administration. The contract has a completion date of December 1, 2022 and includes two 1-year post-warranty maintenance option periods. Axion Biosystems is a life science company that develops technologies for...
- The Food and Drug Administration awarded a $31,950 purchase order to Emulate Inc. on June 18, 2025, for twelve Chip-R1 Rigid Chip basic research kits under a total small business set-aside designation. The contract, which extends to October 16, 2025, represents a firm fixed price procurement of the company's organ-on-chip technology. Emulate Inc., headquartered in Boston, Massachusetts, specializes in microphysiological systems that replicate human organ functions to support advanced...
- The Food and Drug Administration awarded a purchase order to 28Bio, Inc. for Central Nervous System 3D brain organoids neuropharmacological analysis valued at $143,020.98, with an award date of August 1, 2026. Performance is located in Metairie, Louisiana and extends through April 30, 2027. The order calls for functional examination of neuromodulatory effects of a marketed small molecule drug using human CNS 3D brain organoids, including characterization of acute and chronic effects through...
- This is a $152,766 firm fixed price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian federal agency, to the small business Axion Biosystems, Inc. The contract is for Axion's MaestroPro 768-channel multi-electrode array (MEA) system, neural applications software, related MEA plates, installation and training. This specialized equipment is needed to investigate how neural circuit activity changes in response to temperature variations, in order to...
- The U.S. Food and Drug Administration awarded a $200.3K purchase order to Emulate Inc., a Boston-based biotechnology company specializing in organ-on-chip microphysiological systems, for the procurement of a Human Emulation System. The contract, awarded on March 29, 2023, with an ultimate completion date of October 1, 2023, carries a Total Small Business set-aside designation and employs firm fixed-price pricing. The award supports FDA's regulatory science initiatives and efforts to advance...